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The amount of label incorporated into the protein was quantified spectrophotometrically (eJz5 of ABEI = 12 5001itre. mo1-l. cm-') and by chemiluminescence. The molar incorporation ratio was estimated to be 0.2mol of label per mol of IgG. There was no apparent change in the quantum eficiency when the label was attached to the protein, since the estimates of the mol of label/mol of IgG obtained by using absorption or chemiluminescence were the same.
Covalent attachment of the label was established by extensive dialysis, gel filtration and precipitation by trichloroacetic acid (7.5% final concn, > 90% luminescence counts 'precipitated').
The immunoreactivity of the labelled RIgG was demonstrated by allowing it to react with various dilutions of sheep anti-rabbit antiserum coupled to aminocellulose and measuring the luminescent label bound to the solid-phase antiserum. By using 4 x 10-'3mol (0.4pmol) of labelled RIgG, and an appropriate dilution of the solid-phase antiserum, an immunoassay standard curve was obtained for RIgG by direct competitive binding for the labelled RIgG. The standard curve had a similar range as a radioimmunoassay using 'Z51-labelled RIgG (Fig. 1) .
The luminescent-labelled RIgG has been stored at -20°C for several months without any significant loss in its immunological or luminescent activity, whereas the 1z51-labelled RIgG was only stable for 5-6 weeks. It was concluded that ABEI isothiocyanate can label proteins and thus provide safe and stable reagents for use in sensitive immunoassays. These labelled proteins can now be used in combination with fluorescent-labelled antibodies in an attempt to establish a homogenous immunoassay using the principle of radiationless energy transfer (Campbell et al., 1980 Immune responsiveness results from a complex set of interactions between the host, the potential immunogen and its mode and route of presentation. When a humoral immune response to a complex protein antigen is provoked. a population of antibodies is produced that is heterogeneous in specificity and binding affinity. Since a single plasma cell synthesizes antibodies homogenous in primary structure and hence specificity and affinity, it follows that the total antibody response is contributed to by many clones of antibody-secreting cells (i.e. the response is polyclonal). The monoclonal-antibody technique (Kohler & Milstein. 1975 ) allows study of individual components of an antibody response and definition of structures which provoke recognition and antibody production. Antibodies thus characterized may be employed as structural and functional 'probes' in further evaluating antibody activities.
Analysis of antibody responses to several protein antigens (Atassi. 1975 (Atassi. . 1978 has established that: (a) antibody specifically recognizes and binds to discrete structural features (antigenic determinants or epitopes) of the immunogen: (b) epitopes are comprised of five to six amino acid residues that constitute a recognizable topographical feature of the intact protein: (c) the amino acid in such an epitope may be in direct peptide linkage or may be formed by residues brought together by the folding of polypeptide. i.e. the tertiary or quaternary structure. Such epitopes may be termed continuous or discontinuous respectively (Atassi, 1978) .
Our interest is centred on the definition of epitopes within the human immunoglobulins. defined by using murine monoclonal antibodies (Mabs). To this end we have produced a panel of some 30 antibodies directed against the Fc region of human IgGf'. The species cross-reactivity profile of these antibodies (Jefferis et al., 1982) suggests that each is directed against a separate epitope. The Fc region is composed of two polypeptide chains each of which is folded into domains: Cy2 and Cy3. There are cis interactions between Cy2 and Cy3 and trans interactions between Cy3 and Cy3, but not between Cy2 and Cy2. However, the Cy2 domains are held in close spatial arrangement by interchain disulphide linkage at the N-terminal region.
Digestion with pepsin (Heimer et al., 1966) allows isolation of a pFc' fragment, residues Lys-334-Gly-446 (amino acid numbering according to IgGl Eu; Edelman, 1969) . pFc' is essentially a dimer of the Cy3 domain. Of 3 1 anti-Fc Mabs. 17 had reactivity towards this fragment and were thus designated as 'anti-Cy3 antibodies'. The remainder have been assumed to be directed against the Cy2 domain. However. this Cy2 fragment has not been prepared and it is possible that some antibodies will be directed against epitopes dependent on the quaternary structure of the intact native Fc.
In an attempt to further delineate molecular specificity, other fragments of the Cy3 domain have been prepared. Thermolysin (Hunneyball & Stanworth, 1976) yields tlFc' (He-336-Gly-446). and acid trypsin (Ellerson et al.. 1976 ) gave atFc' (residues Glu-345-Lys-439). Digestion with papain (Bennich & Turner, 1969) gave Fc' (residues Gln-342-His-433) (Fig. 1) . Sheep red blood cells sensitized with these fragments (Ling et al., 1977) were agglutinated by all antibodies reactive with the pFc'-sensitized cells. It has been reported that the human pFc' fragment shows a minimum in its far-u.v. c.d. spectrum at 224nm (Dorrington et al., 1972; Stewart et al.. 1976) indicative of a loss of fi-pleated sheet structure. The acid trypsin Fc' and papain Fc' fragments showed a much weaker absorbtion at 224 nm, suggesting further randomization of structure (Ellerson et al., 1976) . We have confirmed these observations (M. 1. N. Jaafar & R. Jefferis, unpublished work) with the fragments generated within the present study. It should be noted that the Vol. 10 
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Lys-334
Gly- Fig. 1 . Schematic drawing of the fragments in the Cy3 domain pFcr, Lys-334-Gly-446: t lFcr, ; and Fc', Gln-342-His-433 [adapted from Edmundson et al. (1975) with permission].
acid-trypsin and papain fragments (Fig. 1 ) lack partially or completely the sequence constituting an element of b-pleated sheet and may be responsible for the changes in c.d. spectra observed. The finding that there is no loss of reactivity with the anti-Cy3 antibodies demonstrated that antibodies to continuous , or discontinuous epitopes dependent on residues 433-446 are not represented within the panel.
Since physical methods suggest marked conformational changes, it may be inferred that Mabs are directed against epitopes of the continuous type. However, it is possible that discontinuous epitopes may be present in an altered form which is still able to bind antibody. Indeed such interaction with antibody may re-establish native conformation. These possibilities may be evaluated by reactivity of the panel of Mabs with fragments which have the disulphide bridge broken by reduction.
The reactivity pattern of one monoclonal antibody, X l a l 1, should be commented on, since it was initially identified as having a higher titre against an Fc fragment than for intact immunoglobulin. Further studies showed that its reactivity with different Fc preparations varied and it was thought that this may relate to denaturation during preparation and purification. This antibody also had a much increased titre (1 : 1 OOOOOO) with the Cy3 fragment than with the intact F c (1 : 5000).
We interpret these data as evidence that X l a l l is directed against an epitope expressed on denatured human IgG and that this epitope is exposed on the Cy3 domain when the Cy2 domain is cleaved from it.
